Radoslaw Spiewak

Prof. Radoslaw Spiewak

Research and Development, Institute of Dermatology, Kraków, Małopolskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
JJJeanne D. Johansen
Jeanne D. Johansen
KAKristiina Aalto‐Korte
Kristiina Aalto‐Korte
TATove Agner
Tove Agner
KAKlaus E. Andersen
Klaus E. Andersen
ABAndreas Bircher
Andreas Bircher
Wolfgang UterWolfgang Uter
Wolfgang Uter
Summary: The present guideline summarizes all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions and discussions of different pertinent topics are followed by a highlighted short practical recommendation. Topics comprise, after an introduction with important definitions, materials, technique, modifications of epicutaneous testing, individual factors influencing the patch test outcome or necessitating special considerations, children, patients with occupational contact dermatitis and drug eruptions as special groups, patch testing of materials brought in by the patient, adverse effects of patch testing, and the final evaluation and patient counselling based on this judgement. Finally, short reference is made to aspects of (continuing) medical education and to electronic collection of data for epidemiological surveillance.

30 December 2021 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
JTJacob P. Thyssen
Jacob P. Thyssen
MSMarie L.A. Schuttelaar
Marie L.A. Schuttelaar
JAJose Hernan Alfonso
Jose Hernan Alfonso
KAKlaus E. Andersen
Klaus E. Andersen
IAIrena Angelova‐Fischer
Irena Angelova‐Fischer
TATove Agner
Tove Agner

20 July 2018 in Allergy
Verified
Journal Article
Closed access
PDF file
KBKnut Brockkow
Knut Brockkow
MAMichael R. Ardern‐Jones
Michael R. Ardern‐Jones
MMMaja Mockenhaupt
Maja Mockenhaupt
WAWerner Aberer
Werner Aberer
ABAnnick Barbaud
Annick Barbaud
CMCharlotte G. Mortz
Charlotte G. Mortz

12 November 2018 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
MWMark Wilkinson
Mark Wilkinson
MGMargarida Gonçalo
Margarida Gonçalo
OAOlivier Aerts
Olivier Aerts
SBSonia Badulici
Sonia Badulici
NBNiels H. Bennike
Niels H. Bennike
Wolfgang UterWolfgang Uter
Wolfgang Uter

1 January 2012 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
NPNikolaos Papadopoulos
Nikolaos Papadopoulos
IAIoana Agache
Ioana Agache
SBSevim Bavbek
Sevim Bavbek
BBBeatrice M Bilo
Beatrice M Bilo
FBFulvio Braido
Fulvio Braido
CACezmi A Akdis
Cezmi A Akdis
In less than half a century, allergy, originally perceived as a rare disease, has become a major public health threat, today affecting the lives of more than 60 million people in Europe, and probably close to one billion worldwide, thereby heavily impacting the budgets of public health systems. More disturbingly, its prevalence and impact are on the rise, a development that has been associated with environmental and lifestyle changes accompanying the continuous process of urbanization and globalization. Therefore, there is an urgent need to prioritize and concert research efforts in the field of allergy, in order to achieve sustainable results on prevention, diagnosis and treatment of this most prevalent chronic disease of the 21stcentury.The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organization in the field of allergy, promoting excellence in clinical care, education, training and basic and translational research, all with the ultimate goal of improving the health of allergic patients. The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is a non‐profit network of allergy, asthma and Chronic Obstructive Pulmonary Disorder (COPD) patients’ organizations. In support of their missions, the present EAACI Position Paper, in collaboration with EFA, highlights the most important research needs in the field of allergy to serve as key recommendations for future research funding at the national and European levels.Although allergies may involve almost every organ of the body and an array of diverse external factors act as triggers, there are several common themes that need to be prioritized in research efforts. As in many other chronic diseases, effective prevention, curative treatment and accurate, rapid diagnosis represent major unmet needs. Detailed phenotyping/endotyping stands out as widely required in order to arrange or re‐categorize clinical syndromes into more coherent, uniform and treatment‐responsive groups. Research efforts to unveil the basic pathophysiologic pathways and mechanisms, thus leading to the comprehension and resolution of the pathophysiologic complexity of allergies will allow for the design of novel patient‐oriented diagnostic and treatment protocols. Several allergic diseases require well‐controlled epidemiological description and surveillance, using disease registries, pharmacoeconomic evaluation, as well as large biobanks. Additionally, there is a need for extensive studies to bring promising new biotechnological innovations, such as biological agents, vaccines of modified allergen molecules and engineered components for allergy diagnosis, closer to clinical practice. Finally, particular attention should be paid to the difficult‐to‐manage, precarious and costly severe disease forms and/or exacerbations. Nonetheless, currently arising treatments, mainly in the fields of immunotherapy and biologicals, hold great promise for targeted and causal management of allergic conditions. Active involvement of all stakeholders, including Patient Organizations and policy makers are necessary to achieve the aims emphasized herein.

13 August 2017 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
Wolfgang UterWolfgang Uter
Wolfgang Uter
JAJ.C. Amario‐Hita
J.C. Amario‐Hita
ABA. Balato
A. Balato
BBB. Ballmer‐Weber
B. Ballmer‐Weber
ABA. Bauer
A. Bauer
SWS.M. Wilkinson
S.M. Wilkinson